Primary thrombophilia in Mexico: A prospective study

American Journal of Hematology

Volumn 60, Issue 1, 1999, Pages 1-5

  Ruiz Argüelles, Guillermo J ^a,b   González Estrada, Sonia ^c   Garcés Eisele, Javier ^b   Ruiz Argüelles, Alejandro ^b  

^a CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

^b Ctro de Hematol y Medicina Interna   (Mexico)

^c Universidad del Noreste   (Mexico)

Author keywords

Factor V Leiden; Mexico; Protein C; Protein C resistance; Protein S; Thrombophilia; Thrombosis

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ARTICLE; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MEXICO; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; SCHOOL CHILD; THROMBOPHILIA;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INDIANS, NORTH AMERICAN; MEXICO; MIDDLE AGED; PHENOTYPE; PREVALENCE; PROSPECTIVE STUDIES; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOSIS;

EID: 0032889452     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199901)60:1<1::AID-AJH1>3.0.CO;2-Q     Document Type: Article

References (41)

1. Florell SR, Rodgers GM. Inherited thrombotic disorders: an update. Am J Hematol 1997;54:53-60.
2. Ruiz-Argüelles GJ. Resistencia a la proteína C activada: una nueva causa de trombofilia. Rev Invest Cĺin Méx 1996;48:223-229.
3. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330:517-522.
4. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-1134.
5. Lisker R, Ramírez E, Pérez-Briceño R, Granados J, Babinsky V. Gene frequencies and admixture estimates in four Mexican urban centers. Hum Biol 1990;62:791-795.
6. Schafer A. The hypercoagulable states. Ann Intern Med 1985;102: 814-828.
7. Ruiz-Argüelles GJ. El laboratorio en el diagnóstico de la enfermedad trombótica y del estado pre-trombótico. Gac Med Méx 1989;125:191-195.
8. Dahlbäck B, Carlsson M, Svensoon PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1994;90:1004-1008.
9. Jorquera JI, Montoro JM, Fernández MA, Aznar JA, Aznar J. Modified test for activated protein C resistance. Lancet 1994;344:1162-1163.
10. Zöller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994;343:1536-1538.
11. Francis RB, Seyfert U. Rapid assay of protein C in whole plasma using an activator from the venom of Agkistrodon contortrix. Am J Clin Pathol 1971;87:619-625.
12. Comp PC, Doray D, Patton D, Esmon CT. An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 1966;67:504-508.
13. Laurell CB, McKay EJ. Electroimmunoassay. In: Colowick SP, Kaplan NO, editors. Methods in enzymology. Vol 73, Part B. Orlando: Academic Press; 1981. p 339-369.
14. Frantzen Handeland G, Abildgaard U, Aasen AO. Simplified assay for antithrombin III activity using chromogenic substrate. Scand J Haematol 1983;31:5427-5436.
15. Soria J, Soria E, Samama M. Plasminogen assay using a chromogenic substrate. Prog Chem Fibrinolysis 1978;3:337-342.
16. Chmielewska J, Ranby M, Wiman B. Evidence of a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983;31:427-436.
17. Urden G, Blömback M. Determination of tissue plasminogen activator inhibitor in plasma samples by means of immunoassay. Scand J Clin Lab Invest 1984;44:495-502.
18. Delezé M, Oria CV, Alarcón-Segovia D. Occurrence of both hemolytic anemia and thrombocytopenic purpura (Evan's syndrome) in systemic lupus erythematosus. Relationship to anti-phospholipid antibodies. J Rheumatol 1988;15:611-615.
19. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Alarcón-Segovia D, Drenkard C, Villa A, Cabiedes J, Presno-Bernal M, Delezé M, Ortiz-López R, Vázquez-Prado J. Natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associates with recent history of venous thrombosis and the antiphospholipid syndrome. J Rheumatol 1991;18:552-558.
20. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Lobato-Mendizábal E, Díaz-Gómez F, Pacheco-Pantoja E, Drenkard C, Alarcón-Segovia D. Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematous. Am J Hematol 1991;37:9-13.
21. Exner T, Papadopoulos G, Koutts J. Use of a simplified dilute Russel viper venom time (dRVVT) confirms heterogeneity among lupus anticoagulants. Blood Coagul Fibrinolysis 1990;259-266.
22. Ruiz-Argüelles GJ, Garcés-Eisele J, Gallaga JC, Cruz-Cruz D, Alarcón-Segovia D. Investigación de la resistencia a la proteína C activada y de la mutación puntual tipo Leiden en el gen del factor V de la coagulación en pacientes con trombofilia [abstract]. Sangre 1995;40: 250.
23. Alarcón-Segovia D, Ruiz-Argüelles GJ, Garcés-Eisele J, Ruiz-Argüelles A. Inherited activated protein C resistance in a patient with familial antiphospholipid syndrome. J Rheumatol 1996;23:2162-2165.
24. Césarman G, Villazón S, Zúñiga J, Rosillo C, Vahedian M, Stopeck A, Granados J. Absence of factor V Leiden mutation in Mazateco Indians: a polymorphism of recent acquisition in the Americas. Int J Haematol 1996;64(Suppl 1):s111.
25. Dahlbäck B. Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism. J Intern Med 1995;237:221-227.
26. Ruiz-Argüelles GJ. Promyelocytic leukemia in Mexican Mestizos. Blood 1997;89:348-349.
27. Ruiz-Argüelles GJ, Garcés Eisele J, Alarcón-Segovia D, Ruiz-Argüelles A. Activated protein C resistance phenotype and genotype in patients with primary antiphospholipid syndrome. Blood Coagul Fibrinolysis 1996;7:344-348.
28. Ruiz-Argüelles GJ. Protein C resistance and antiphospholipid antibodies. Lupus 1996;5:633.
29. Pötzsch B, Kawamura H, Preissner KT, Schmidt M, Seelig C, Müller-Berghaus G. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant. J Lab Clin Med 1995;125:56-65.
30. Aznar J, Villa P, España F, Estellés A, Grancha S, Falcó C. Activated protein C resistance phenotype in patients with antiphospholipid antibodies. J Lab Clin Med 1997;130:202-208.
31. Granados J, Vargas-Alarcón G, Andrade F, Melín-Aldana H, Alcocer-Varela J, Alarcón-Segovia D. The role of HLA-DR alleles and complotypes through the ethnic barrier in systemic lupus erythematosus in Mexicans. Lupus 1996;5:184-189.
32. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Velázquez BM. Serum lipoprotein (a) levels are increased in patients with the antiphospholipid syndrome and might be associated to thrombophilia. Clin Appl Thromb/ Hemostasis 1996;2:148-149.
33. Ruiz-Argüelles A, Vázquez-Prado J, Delezé M, Pérez-Romano B, Drenkard C, Alarcón-Segovia D, Ruiz-Argüelles GJ. Presence of serum antibodies to coagulation protein C in patients with systemic lupus erythematosus is not associated with antigenic or functional protein C deficiencies. Am J Hematol 1993;44:58-59.
34. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, Alarcón-Segovia D. Protein S deficiency associated to anti-protein S antibodies in a patient with mixed connective-tissue disease and its reversal by danazol. Acta Haematol 1993;89:206-208.
35. Ruiz-Argüelles A, Anglés-Cano E, Pérez-Romano B, Ruiz-Argüelles GJ, Delezé M, Alarcón-Segovia D, Gaussem P. Serum antibodies to distinct epitopes of the tissue-type plasminogen activator in patients with systemic lupus erythematosus. Am J Hematol 1995;49:109-114.
36. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Delezé M, Alarcón-Segovia D. Acquired protein C deficiency in a patient with primary antiphospholipid syndrome. Relationship to reactivity of the anticardiolipin antibody with thrombomodulin. J Rheumatol 1989;16:381-383.
37. Bernardi F, Faioni EM, Castoldi E, Lunghi B, Castaman G, Sacchi E, Mannucci PM. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 1997;90:1552-1557.
38. Lobato-Mendizábal E, Anaya-Galindo R, Ruiz-Argüelles A, Galicia-Reyes A, Ruiz-Argüelles GJ. Identificación del primer paciente mexicano con deficiencia congénita de proteína C de la coagulacion [abstract]. Sangre 1987;32:260.
39. Lobato-Mendizábal E, Ruiz-Argüelles GJ. Proteína C, proteína S y trombomodulina: uno de los mecanismos antitrombóticos naturales. Rev Invest Clín Méx 1990;42:54-62.
40. Bokarewa MI, Blömback M. Combination of activated protein C resistance and antibodies to phospholipids in the development of thrombosis. Semin Hematol 1997;34:235-243.
41. Arends T, Arends A. Introducción a la hematología geográfica en Iberoamérica. In: López-Borrasca A, Arocha-Piñango CL, Campos-Guerra C, Parreira A, Pavlovsky S, Ruiz-Argüelles GJ, San Miguel F, editors. Enciclopedia Iberoamericana de Hematología. Salamanca, Spain: Ediciones Universidad de Salamanca; 1992. p IV-601-605.